3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
3
Vaginal Neoplasms
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroendocrine Tumors
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Gallbladder Neoplasms
1
Blast Crisis
1
Interventions
fludarabine phosphate
41
Peripheral Blood Stem Cell Transplantation
36
Cytarabine
32
Cyclophosphamide
31
Whole-Body Irradiation
30
Busulfan
30
Tacrolimus
28
Mycophenolic Acid
27
Methotrexate
18
Etoposide
18
Cyclosporine
18
Antilymphocyte Serum
16
Filgrastim
15
Melphalan
13
Granulocyte Colony-Stimulating Factor
11
Idarubicin
10
Flow Cytometry
9
Clofarabine
9
Daunorubicin
8
sargramostim
7
Radiotherapy
7
Mitoxantrone
7
Cord Blood Stem Cell Transplantation
7
Transplantation
6
Thiotepa
6
Sirolimus
6
merphos
5
fludarabine
5
aldesleukin
5
Vorinostat
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Congenital Abnormalities
×
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
×
Clear all
No trials found.